Financhill
Back

Geron 10K Form

Buy
65

GERN
Geron

Last Price:
3.31
Seasonality Move:
6.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive GERN News And Ratings

See the #1 stock for the next 7 days that we like better than GERN

GERN Financial Statistics

Sales & Book Value

Annual Sales: $237K
Cash Flow: $-41M
Price / Cash Flow: 0
Annual Sales: $0.46
Price / Book: 7.33

Profitability

EPS (TTM): -0.33000
Net Income (TTM): $-184.13M
Gross Margin: $0
Return on Equity: -74.06%
Return on Assets: -50.09%

Geron Earnings Forecast

Key Geron Financial Ratios

  • The Gross Profit Margin over the past 21 years for GERN is 0.00%.
  • The Selling, General & Administrative Expenses for GERN have been equal to 29,170.89% of Gross Profit Margin.
  • The Research & Development expenses have been 52,762.03% of Revenue.
  • The Interest Expense is -4.51% of Operating Income.
  • The Net Earning history of GERN is -77,690.72% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 16 years.

Geron Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: GERN
CUSIP: 374163
Website: geron.com

Debt

Debt-to-Equity Ratio: 0.33
Current Ratio: 3.16
Quick Ratio: 3.1

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

GERN Technical Analysis vs Fundamental Analysis

Buy
65
Geron (GERN) is a Buy

Is Geron a Buy or a Sell?

  • Geron stock is rated a Buy
    The current Geron [GERN] share price is $3.33. The Score for GERN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.